PubMed for id: 1676324969

Year	Number of Results
1991	1
1992	3
1995	1
2023	1
2024	5

1

Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.

Horesh ME, Martin-Fernandez M, Gruber C, Buta S, Le Voyer T, Puzenat E, Lesmana H, Wu Y, Richardson A, Stein D, Hodeib S, Youssef M, Kurowski JA, Feuille E, Pedroza LA, Fuleihan RL, Haseley A, Hovnanian A, Quartier P, Rosain J, Davis G, Mullan D, Stewart O, Patel R, Lee AE, Rubinstein R, Ewald L, Maheshwari N, Rahming V, Chinn IK, Lupski JR, Orange JS, Sancho-Shimizu V, Casanova JL, Abul-Husn NS, Itan Y, Milner JD, Bustamante J, Bogunovic D. Horesh ME, et al. J Exp Med. 2024 Jun 3;221(6):e20232387. doi: 10.1084/jem.20232387. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563820

2

CD146⁺CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10/JAK1/STAT3 pathway.

Yu Z, Zhang Q, Wei S, Zhang Y, Zhou T, Zhang Q, Shi R, Zinovkin D, Pranjol ZI, Zhang J, Wang H. Yu Z, et al. Cell Commun Signal. 2024 Mar 8;22(1):170. doi: 10.1186/s12964-024-01550-9. Cell Commun Signal. 2024. PMID: 38459564 Free PMC article.

3

Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.

Cheng B, Li L, Luo T, Wang Q, Luo Y, Bai S, Li K, Lai Y, Huang H. Cheng B, et al. J Exp Clin Cancer Res. 2024 Mar 1;43(1):67. doi: 10.1186/s13046-024-02962-8. J Exp Clin Cancer Res. 2024. PMID: 38429845 Free PMC article.

4

WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/JAK1/STAT3 signaling.

Huang Q, Xiao Y, Lan T, Lu Y, Huang L, Zheng D. Huang Q, et al. Int J Oral Sci. 2024 Jan 22;16(1):7. doi: 10.1038/s41368-024-00279-y. Int J Oral Sci. 2024. PMID: 38246919 Free PMC article.

5

Inhibiting JAK1, not NF-κB, reverses the effect of pro-inflammatory cytokines on engineered human ligament function.

Avey AM, Devos F, Roberts AG, Essawy ESE, Baar K. Avey AM, et al. Matrix Biol. 2024 Jan;125:100-112. doi: 10.1016/j.matbio.2023.12.007. Epub 2023 Dec 25. Matrix Biol. 2024. PMID: 38151137 Free article.

6

Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases.

Johnston JA, Wang LM, Hanson EP, Sun XJ, White MF, Oakes SA, Pierce JH, O'Shea JJ. Johnston JA, et al. J Biol Chem. 1995 Dec 1;270(48):28527-30. doi: 10.1074/jbc.270.48.28527. J Biol Chem. 1995. PMID: 7499365 Free article.

7

Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.

Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zürcher G, Ziemiecki A. Wilks AF, et al. Mol Cell Biol. 1991 Apr;11(4):2057-65. doi: 10.1128/mcb.11.4.2057-2065.1991. Mol Cell Biol. 1991. PMID: 1848670 Free PMC article.

8

Two members of the JAK family of protein tyrosine kinases map to chromosomes 1p31.3 and 9p24.

Pritchard MA, Baker E, Callen DF, Sutherland GR, Wilks AF. Pritchard MA, et al. Mamm Genome. 1992;3(1):36-8. doi: 10.1007/BF00355839. Mamm Genome. 1992. PMID: 1581631

9

A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

Velazquez L, Fellous M, Stark GR, Pellegrini S. Velazquez L, et al. Cell. 1992 Jul 24;70(2):313-22. doi: 10.1016/0092-8674(92)90105-l. Cell. 1992. PMID: 1386289

10

Characterization of a class 3 tyrosine kinase.

Howard OM, Dean M, Young H, Ramsburg M, Turpin JA, Michiel DF, Kelvin DJ, Lee L, Farrar WL. Howard OM, et al. Oncogene. 1992 May;7(5):895-900. Oncogene. 1992. PMID: 1373877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year